Literature DB >> 12558615

Lower heart rate response to ergometry rowing than to treadmill running in older men.

Chie C Yoshiga1, Mitsuru Higuchi, Jun Oka.   

Abstract

For older people exercise intensity is often determined based on heart rate (HR) or the percentage of maximal HR (%HRmax). This study evaluated oxygen uptake (O2) and HR during ergometry rowing (combined arm and leg; sitting exercise) and treadmill running (leg; upright exercise) for 15 older people [age, (mean +/- SD) 62 +/- 3 years]. The HR was lower during ergometry rowing than during treadmill running at a blood lactate concentration of 4 mmol l-1 (151 +/- 4 beat min-1 versus 160 +/- 5 beat min-1, P<0.05) and at a maximal effort (171 +/- 7 beat min-1 versus 177 +/- 7 beat min-1, P<0.05). This was the case although the O2 was higher during ergometry rowing than during treamill running both at a blood lactate concentration of 4 mmol l-1 (3.0 +/- 0.4 l min-1 versus 2.7 +/- 0.4 l min-1, P<0.05) and at a maximal effort (3.4 +/- 0.4 l min-1 versus 3.1 +/- 0.3 l min-1, P<0.05]. %HRmax and %HR reserve were lower during ergometry rowing than during treadmill running. The results suggest that, in prescription of rowing for older people, the relation between HR and O2 for rowing and the attenuated HR response to rowing should be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558615     DOI: 10.1046/j.1475-097x.2003.00470.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  2 in total

1.  Concurrent and Construct Validation of a Scale for Rating Perceived Exertion in Aquatic Cycling for Young Men.

Authors:  Juan C Colado; Roxana M Brasil
Journal:  J Sports Sci Med       Date:  2019-11-19       Impact factor: 2.988

2.  Validation and Practical Applications of Performance in a 6-Min Rowing Test in the Danish Armed Forces.

Authors:  Oliver Funch; Henriette A Hasselstrøm; Thomas P Gunnarsson
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.